Status:
UNKNOWN
The Diagnostic Value of PET/MRI in Head and Neck Cancer
Lead Sponsor:
Odense University Hospital
Collaborating Sponsors:
University of Southern Denmark
Conditions:
Squamous Cell Carcinoma of Head and Neck
Head and Neck Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study investigates the diagnostic value of PET/MRI for cervical lymph node metastases from head and neck squamous cell carcinomas.
Detailed Description
The Danish fast-track cancer program standardizes the work-up of patients suspected of head and neck cancer. Currently, the guidelines recommend head and neck magnetic resonance imaging (MRI) as the s...
Eligibility Criteria
Inclusion
- Patients either suspected of or with histologically verified:
- Relapse of head and neck squamous cell cancer with involvement of regional lymph node(s)
- Cervical lymph node metastasis with unknown primary tumor site
- Oral cavity squamous cell carcinoma
- Oropharyngeal squamous cell cancer planned for trans oral robotic surgery
Exclusion
- Patients who cannot have a PET/MRI performed for different reasons (allergy, claustrophobia, medical implants)
- Patients who had surgery, infection or other inflammatory inducing conditions on the neck within the last 8 weeks
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2022
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT04117139
Start Date
October 1 2019
End Date
September 30 2022
Last Update
October 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of ORL - Head & Neck Surgery and Audiology, Odense University Hospital
Odense, Denmark, 5000